Revance Provides Corporate Update and Anticipated Milestones for 2021
Press release content from Business Wire. The AP news staff was not involved in its creation. Revance Provides Corporate Update and Anticipated Milestones for 2021 January 7, 2021 GMT NASHVILLE, Tenn.--(BUSINESS WIRE)--Jan 7, 2021-- Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today provided a corporate update, product pipeline timing and anticipated milestones for 2021. Financial Update and Key Launch Metrics: Preliminary Unaudited Full Year 2020 RHA® Collection Revenue of Between $12.5 Million and $13.0 Millio...
Source: apnews.com